AEON Biopharma, Inc. (AEON) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

AEON Biopharma, Inc. (AEON) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $8.9M, listed on AMEX, employing roughly 5 people, carrying a beta of 0.61 to the broader market. AEON Biopharma, Inc. Led by Robert Bancroft, public since 2023-07-24.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for AEON as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →